Controversy swirls around Covishield vaccine as lawsuits in India and UK raise concerns over adverse effects, prompting AstraZeneca to withdraw its supply amid decreased demand.
According to Foreign Ministry Sources, the Central Government has reportedly put on temporary hold all major exports of Oxford-AstraZeneca’s Covishield vaccine.